That is the evidence gap, stated plainly: the mechanism is well-motivated and the preclinical signal is consistent, but no human study has confirmed that any of it translates to people, at any dose, by any route
Respiratory and Systemic Regeneration Applications Respiratory and systemic regeneration applications use 2 mg subcutaneous 2-3x weekly for general tissue repair and anti-inflammatory effects, running 8-12 week cycles with 4-6 week breaks
Evaporation, precipitation, transportation, and sublimation C
Blood Flow, Nitric Oxide, and Angiogenesis BPC 157 may also influence nitric oxide pathways and angiogenesis
Clinical consequences of toxic envenomations by Hymenoptera